Lantheus Holdings News and Activities

Presence

Lantheus Holdings develops and sells diagnostic imaging and radiopharmaceutical products. Its products and services support hospitals, imaging centers, and healthcare providers in disease detection, treatment planning, and patient management.

Lantheus Holdings products and services overview:

Diagnostic imaging
Radiopharmaceuticals
Cardiology imaging
Oncology imaging
Ultrasound imaging
Imaging services

Revenue: ~$2 billion

Employees: 800

Headquarters: Bedford, United States (USA)

Lantheus Holdings is one of the...

Lantheus Holdings is a company listed under the stock ticker LNTH (US).

They are in:

Pharmaceuticals50%
Biotechnology50%

Acquisition, funding and merger involving Lantheus Holdings.

Curium Pharma has announced the acquisition of Lantheus Holdings (posted on May 29 2026).
Lantheus Holdings has acquired Evergreen Theragnostics (posted on April 2 2025).
Lantheus Holdings has acquired Life Molecular Imaging (posted on January 24 2025).

Executives

View the org chart displaying its 36 main executives

Most searched biographies at Lantheus Holdings

Popular executive movements at Lantheus Holdings

Andrew Stephens, Senior Vice President, Clinical Development, has left the company (posted on May 29 2026).
Jean-Claude Provost, Chief Science Officer, has left the company (posted on May 29 2026).
Paul Blanchfield, President , has left the company (posted on November 11 2025).

Click here to view some more movements at Lantheus Holdings

Create your alert
to follow the executive moves at Lantheus Holdings.